169 related articles for article (PubMed ID: 38648487)
1. Single-chain fluorescent integrators for mapping G-protein-coupled receptor agonists.
Kroning K; Gannot N; Li X; Putansu A; Zhou G; Sescil J; Shen J; Wilson A; Fiel H; Li P; Wang W
Proc Natl Acad Sci U S A; 2024 Apr; 121(18):e2307090121. PubMed ID: 38648487
[TBL] [Abstract][Full Text] [Related]
2. Single-chain fluorescent integrators for mapping G-protein-coupled receptor agonists.
Kroning K; Gannot N; Li X; Zhou G; Sescil J; Putansu A; Shen J; Wilson A; Fiel H; Li P; Wang W
bioRxiv; 2023 Jun; ():. PubMed ID: 37398137
[TBL] [Abstract][Full Text] [Related]
3. Designing a Single Protein-Chain Reporter for Opioid Detection at Cellular Resolution.
Kroning KE; Wang W
Angew Chem Int Ed Engl; 2021 Jun; 60(24):13358-13365. PubMed ID: 33662184
[TBL] [Abstract][Full Text] [Related]
4. Sortase ligation enables homogeneous GPCR phosphorylation to reveal diversity in β-arrestin coupling.
Staus DP; Wingler LM; Choi M; Pani B; Manglik A; Kruse AC; Lefkowitz RJ
Proc Natl Acad Sci U S A; 2018 Apr; 115(15):3834-3839. PubMed ID: 29581292
[TBL] [Abstract][Full Text] [Related]
5. Differential influence of D1 and D2 dopamine receptors on acute opiate withdrawal in guinea-pig isolated ileum.
Capasso A; Sorrentino L
Br J Pharmacol; 1997 Mar; 120(6):1001-6. PubMed ID: 9134209
[TBL] [Abstract][Full Text] [Related]
6. Agonist-selective recruitment of engineered protein probes and of GRK2 by opioid receptors in living cells.
Stoeber M; Jullié D; Li J; Chakraborty S; Majumdar S; Lambert NA; Manglik A; von Zastrow M
Elife; 2020 Feb; 9():. PubMed ID: 32096468
[TBL] [Abstract][Full Text] [Related]
7. Differential effects of opioid agonists on G protein expression in CHO cells expressing cloned human opioid receptors.
Xu H; Wang X; Partilla JS; Bishop-Mathis K; Benaderet TS; Dersch CM; Simpson DS; Prisinzano TE; Rothman RB
Brain Res Bull; 2008 Sep; 77(1):49-54. PubMed ID: 18639745
[TBL] [Abstract][Full Text] [Related]
8. Differences among mouse strains in the regulation by mu, delta 1 and delta 2 opioid receptors of striatal adenylyl cyclases activated by dopamine D1 or adenosine A2a receptors.
Noble F; Cox BM
Brain Res; 1996 Apr; 716(1-2):107-17. PubMed ID: 8738226
[TBL] [Abstract][Full Text] [Related]
9. Identifying Functional Hotspot Residues for Biased Ligand Design in G-Protein-Coupled Receptors.
Nivedha AK; Tautermann CS; Bhattacharya S; Lee S; Casarosa P; Kollak I; Kiechle T; Vaidehi N
Mol Pharmacol; 2018 Apr; 93(4):288-296. PubMed ID: 29367258
[TBL] [Abstract][Full Text] [Related]
10. Interactions between kappa and mu opioid receptor agonists: effects of the ratio of drugs in mixtures.
Minervini V; Lu HY; Padarti J; Osteicoechea DC; France CP
Psychopharmacology (Berl); 2018 Aug; 235(8):2245-2256. PubMed ID: 29785554
[TBL] [Abstract][Full Text] [Related]
11. GPR88 reveals a discrete function of primary cilia as selective insulators of GPCR cross-talk.
Marley A; Choy RW; von Zastrow M
PLoS One; 2013; 8(8):e70857. PubMed ID: 23936473
[TBL] [Abstract][Full Text] [Related]
12. Differential effects of micro-opioid, delta-opioid and kappa-opioid receptor agonists on dopamine receptor agonist-induced climbing behavior in mice.
Ito S; Mori T; Sawaguchi T
Behav Pharmacol; 2006 Dec; 17(8):691-701. PubMed ID: 17110795
[TBL] [Abstract][Full Text] [Related]
13. Spatiotemporal Characterization of GPCR Activity and Function during Endosomal Trafficking Pathway.
Kim H; Lee HN; Choi J; Seong J
Anal Chem; 2021 Feb; 93(4):2010-2017. PubMed ID: 33400862
[TBL] [Abstract][Full Text] [Related]
14. Mixed κ/μ partial opioid agonists as potential treatments for cocaine dependence.
Bidlack JM
Adv Pharmacol; 2014; 69():387-418. PubMed ID: 24484983
[TBL] [Abstract][Full Text] [Related]
15. Muscarinic acetylcholine receptor modulation of mu (mu) opioid receptors in adult rat sphenopalatine ganglion neurons.
Margas W; Mahmoud S; Ruiz-Velasco V
J Neurophysiol; 2010 Jan; 103(1):172-82. PubMed ID: 19889856
[TBL] [Abstract][Full Text] [Related]
16. Genetically encoded tools for in vivo G-protein-coupled receptor agonist detection at cellular resolution.
Kroning KE; Wang W
Clin Transl Med; 2022 Dec; 12(12):e1124. PubMed ID: 36446954
[TBL] [Abstract][Full Text] [Related]
17. [The mu, delta and kappa properties of various opioids].
Ohta S; Niwa M; Nozaki M; Hattori M; Shimonaka H; Dohi S
Masui; 1995 Sep; 44(9):1228-32. PubMed ID: 8523655
[TBL] [Abstract][Full Text] [Related]
18. N-naphthoyl-beta-naltrexamine (NNTA), a highly selective and potent activator of μ/kappa-opioid heteromers.
Yekkirala AS; Lunzer MM; McCurdy CR; Powers MD; Kalyuzhny AE; Roerig SC; Portoghese PS
Proc Natl Acad Sci U S A; 2011 Mar; 108(12):5098-103. PubMed ID: 21385944
[TBL] [Abstract][Full Text] [Related]
19. Effects of the novel, selective and low-efficacy mu opioid receptor ligand NAQ on intracranial self-stimulation in rats.
Altarifi AA; Yuan Y; Zhang Y; Selley DE; Negus SS
Psychopharmacology (Berl); 2015 Feb; 232(4):815-24. PubMed ID: 25178814
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and opioid receptor affinity of morphinan and benzomorphan derivatives: mixed kappa agonists and mu agonists/antagonists as potential pharmacotherapeutics for cocaine dependence.
Neumeyer JL; Bidlack JM; Zong R; Bakthavachalam V; Gao P; Cohen DJ; Negus SS; Mello NK
J Med Chem; 2000 Jan; 43(1):114-22. PubMed ID: 10633042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
